gsk706769
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00539201)
Timeline
Indications
Mechanism of action
- C-C motif chemokine 5INHIBITOR
CCL5 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk706769
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00979771 | Phase 2 | Feb 1, 2010 | GlaxoSmithKline |
| NCT00975936 | Phase 1 | Sep 21, 2009 | GlaxoSmithKline |
| NCT00723775 | Phase 1 | Jul 1, 2008 | GlaxoSmithKline |
| NCT00711386 | Phase 1 | May 1, 2008 | GlaxoSmithKline |
| NCT00539201 | Phase 1 | Sep 1, 2007 | GlaxoSmithKline |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 5 | 5 | 2 | 2007 |
1 organizations
Page 1 / 1